A phase 3 open label, randomized, multicenter study of N

Project: Research project

Project Details

Description

A phase 3 open label, randomized, multicenter study of NKTR-102 versus treatment of physician's choice (TPC) in patients with metastatic breast cancer who have stable brain metastases and have been
StatusActive
Effective start/end date11/1/1611/30/22

Funding

  • NEKTAR THERAPEUTICS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.